Volume 13, Number 9—September 2007
Letter
Recurrent American Cutaneous Leishmaniasis
Jean-Pierre Gangneux*
, Sylvie Sauzet†, Sébastien Donnard†, Nicolas Meyer*, Anne Cornillet*, Francine Pratlong‡, and Claude Guiguen*
, Sylvie Sauzet†, Sébastien Donnard†, Nicolas Meyer*, Anne Cornillet*, Francine Pratlong‡, and Claude Guiguen*
Table
Epidemiologic characteristics, strain identification, and treatment of 21 cases of American cutaneous leishmaniasis, French Guiana, 2004–2005*
| Case no. | Primary infection |
Leishmaniasis recidiva cutis |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Lesion(s), location (no.) | PI treatment† | Time to healed lesions, mo | Disease-free interval, mo | Direct examination | Strain identification | PI treatment | Outcome | ||
| 1 | Thorax (1) | IV, 4 mg/kg on alternate days × 3 | 1 | 4 | + | Leishmania guyanensis MON-45 | IV, 4 mg/kg on alternate days × 4 | Cured | |
| 2 | Right forearm (1) | IV, 4 mg/kg on alternate days × 3 | 3 | 6 | + | L. guyanensis MON-45 | IV, 4 mg/kg on alternate days × 4 | Cured | |
| 3 | Left leg (1) and chin (3) | IV, 4 mg/kg on alternate days × 3 | 1 | 4 | + | Negative culture | IV, 4 mg/kg on alternate days × 4 | Cured | |
| 4 | Chin (3) | IV, 4 mg/kg on alternate days × 3 | 1 | 4 | + | Negative culture | IV, 4 mg/kg on alternate days × 4 | Cured | |
| 5 | Behind left ear (1) | IV, 4 mg/kg on alternate days × 3 | 1 | 3 | + | L. guyanensis MON-131 | IV, 4 mg/kg on alternate days × 4 | Cured | |
| 6 | Left ear (1) | IV, 4 mg/kg on alternate days × 3 | 1 | 6 | + | Negative culture | IV, 4 mg/kg on alternate days × 4 | Cured | |
| 7 | Right ankle (5) | IV, 4 mg/kg on alternate days × 3 | 2.5 | 4 | + | Negative culture | IV, 4 mg/kg on alternate days × 4 | Cured | |
| 8–21 | Various | IV, 4 mg/kg on alternate days × 3 (for 9 patients) or IM, 4 mg/kg on alternate days × 2 (for 5 patients)† | 1–3 | – | – | – | – | – | |
*PI, pentamidine isethionate; IV, intravenous; IM, intramuscular.
†IV versus IM administration of pentamidine isethionate was not associated with recurrent forms.
Page created: July 01, 2010
Page updated: July 01, 2010
Page reviewed: July 01, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.